Charlottesville researcher receives national award

March 21, 2000

Techniques yield information that could lead to cancer vaccines

Chemist Donald F. Hunt of Charlottesville, Va., will be honored on March 28 by the world's largest scientific society for developing techniques whose uses include identifying disease markers on unhealthy cells -- isolating a single protein among a cell's thousands. He will receive the Frank H. Field and Joe L. Franklin Award for Outstanding Achievement in Mass Spectrometry from the American Chemical Society at its national meeting in San Francisco.

"Each kind of cell in the body expresses about 20,000 different proteins," began Hunt, a professor of chemistry and pathology at the University of Virginia. "What I can do is take cells, break them open and tell what kind of proteins they have."

One goal is to determine which of the 10,000 molecules bristling on a cell's surface trigger the immune system to recognize disease ‹ information that can help researchers develop vaccines against cancer. "Every cell takes a little piece of the proteins it's making and puts them on its surface," Hunt explained. "The immune system checks through these amino acid chains. If it recognizes them as fragments of cancer proteins, for example, it attacks the cell."

Hunt's team of researchers was the first to sift through and identify fragments that stimulate the immune system to attack and kill melanoma, or skin cancer. This entailed determining the sequence of amino acids, tracing them back to their original cell proteins, and studying how they are transported to the surface.

Hunt developed these techniques with a mass spectrometer, which identifies molecules by their electrical charge and mass. The instrument is also used to test Olympic athletes for drugs, analyze forensic evidence and determine the ages of rocks.

Two childhood companions played a large role in Hunt's decision to become a chemist. "One boy's father used to gave us math puzzles to keep us quiet," he remembered. "That led us to his Scientific Americans, looking for more math puzzles." When an older brother asked the three what they wanted to be, one said "mathematician," the other said "physicist" and Hunt said "chemist." He continued, "And you know, we each became what we said that day."

A nonprofit organization with a membership of 161,000 chemists and chemical engineers, the American Chemical Society publishes scientific journals and databases, convenes major research conferences, and provides educational, science policy and career programs in chemistry. Its main offices are in Washington, D.C., and Columbus, Ohio.

American Chemical Society

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to